Press Releases
 
HIV Market Research by Key players, Type and Application, Future Growth to 2020

, 10 December 2018 -- HIV Market Analysis by Recent Trends, Development and Growth Forecast by Regions and Applications to 2020

Human Immune-deficiency Virus (HIV) is one of the most widespread, catastrophic, incurable diseases among humans throughout the world. According to the 2013 report by World Health Organization (WHO), HIV ranked 6th among the global deaths throughout the world, with approximately 1,776,270 deaths in 2009 itself. HIV presents itself as a complex mix of symptoms, all related to severe immune compromise. The global HIV market, according to the Financial Times 2015, was around USD 20 billion in 2013, which ranks it along with the global insulin market. High quality global journalism requires investment. Globally, the annual deaths from HIV/AIDS have fallen from 2.3 million in 2005 to 1.5 million in 2013, according to the UN AIDS report. HIV antivirals are the largest segment of drugs in the HIV market. Pharmaceutical companies however are focusing on the research and development of novel drugs that prove to be a long term cure for HIV virus and shall forever suppress the virus throughout the life of an individual.

View Report: https://www.transparencymarketresearch.com/hiv-market.html

Treatments also involve dietary modifications and symptomatic relief of conditions presented during the onset of AIDS. Therapeutic treatment is often costly and requires constant supply of energy compounds (sugar/fat) in order for the patient to maintain a standard daily requirement. The affordability of such treatments is a factor of concern in many developing countries of the world. Furthermore, highest number of HIV-infected people is witnessed in poor countries. There is a majority of the HIV infected population living in sub-Saharan Africa region. Hence, worldwide healthcare companies are ensuring to lower their costs in this region so that they can introduce their products to generic competition.

That said, the market for HIV therapeutics potentially remains in billions, with new patent trials being conducted every year. HIV market therefore remains highly attractive in terms of novel drugs and their impact globally. Asian manufacturers are proving to be a tough competition with their unique patent laws that circumvent patent of essential life saving medicines. The prices too are bound to decrease with the entry of such manufacturers, thereby potentially increasing therapeutics market in terms of volume. The North American HIV market is the highest market globally, by value and occupies more than 50% of the global revenue generated from HIV antiviral; this is followed by the European market at around 30% of the global market. The growth in these regions is mainly attributed to high affordability of drugs along with a range of health insurance coverage. In developing markets of Asia and South America, the leading cause of death is their poor healthcare standards. This along with their population size make for a potentially large market, however unavailability of affordable drugs is often the reason why markets haven’t been proliferated as of yet. On the other hand, the recent growth of market in Asia Pacific is a positive sign for potential manufacturers. The rest of the world also follows a similar pattern like Asia. Overall the Asian, African and South American region contribute less than 20% share in the global HIV market.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=113

Some of the well known companies manufacturing HIV drugs are: Bristol-Myers Squibb Company, ViiV Healthcare (Pfizer Inc.) and GlaxoSmithKline plc, Gilead Sciences Inc., Boehringer Ingelheim (C.H. Boehringer Sohn AG & Ko. KG), F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Janssen Therapeutics, Merck & Co. Inc., Cipla Limited, and others, to name a few.

Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=113

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com

# # #


Submitted by hawer on Monday, 10 December 2018 at 9:37 PM
Category: Health Care & Medical
 
Related News

Blood Component Extractor Market Current Trends and Future Aspect Analysis 2016-2024
Tuesday, 26 Mar 2019

Diuretic Agents Market Future Opportunities 2025
Monday, 25 Mar 2019

Betalactam Drugs Market Size, Status and Forecast to 2025
Monday, 25 Mar 2019

Antihyperlipidemic Drugs Market: Shares, Strategies and Forecasts, Analysis and Overview upto 2025
Monday, 25 Mar 2019

Polio Market Growth Opportunities & Technology Developments by 2025
Monday, 25 Mar 2019

Related Events

Diagnostic Imaging Update on Kauai
Monday, 25 Mar 2019

Medical Device Safety and Reporting Summit
Monday, 25 Mar 2019

8th Drug Formulation and Bioavailability
Monday, 25 Mar 2019

Slow- and Controlled-Release and Stabilized Fertilizers (SCRSFs)
Monday, 25 Mar 2019

3rd Product Complaints Forum
Monday, 25 Mar 2019

Latest News

Blood Component Extractor Market Current Trends and Future Aspect Analysis 2016-2024
Tuesday, 26 Mar 2019

Andre Porter Book to Film Tour
Tuesday, 26 Mar 2019

Safezone.Tips Stand The Best Place Online To Get Free SafeZone Pass To Start Exploring
Monday, 25 Mar 2019

New Silkroutes Group sells its energy unit for US$10 million
Monday, 25 Mar 2019

Rent a Wedding Dress That Fits From Esther Wedding Dress at the Best Cost
Monday, 25 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 26 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: CCISDA Spring Conference 2019
  • Diagnostic Imaging Update on Kauai
  • 2nd Pharmacovigilance Audit and Inspection Conference
  • Medical Device Safety and Reporting Summit
  • 8th Drug Formulation and Bioavailability

  • Latest Jobs
    Sorry, there are currently no entries posted here.